Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
41 pages
Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...
May 2022
41 pages
Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA,...
May 2022
180 pages
Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
192 pages
Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
61 pages
Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
180 pages
Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
53 pages
Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
38 pages
Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
51 pages
Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...
May 2022
35 pages
Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
39 pages
Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
35 pages
Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 3,500.00
Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications,...
May 2022
197 pages
Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
37 pages
Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages,...
May 2022
168 pages
Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
42 pages
Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
35 pages
Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule...
May 2022
37 pages
Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, Mo...
May 2022
46 pages
Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
250 pages
Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
44 pages
Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Mole...
May 2022
132 pages
Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...
May 2022
91 pages
